Results 181 to 190 of about 50,656 (201)

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

Nature Medicine, 2003
Matthew J During, Helen L Fitzsimons, Matthias Klugmann   +2 more
exaly  

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

Circulation, 2008
Kiwon Ban, Mansoor Husain
exaly  

Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension

Arteriosclerosis, Thrombosis, and Vascular Biology, 2020
Katie Frenis, Sanela Kalinovic, Kamil Kus   +2 more
exaly  

Intracellular Signals Mediating the Food Intake-Suppressive Effects of Hindbrain Glucagon-like Peptide-1 Receptor Activation

Cell Metabolism, 2011
Matthew R Hayes, Bart C De Jonghe, Scott E Kanoski   +2 more
exaly  

Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice

Cell Metabolism, 2017
Haruka Okamoto, Wen-hong Li, Jesper Gromada   +2 more
exaly  

Chapter 13: Glucagon-Like Peptide-1 Receptor Agonists

2022
openaire   +1 more source

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

Lancet, The, 2022
exaly  

Glucagon-like peptide-1 receptor agonists and aspiration risk

BMJ
Daniel I, McIsaac, Gregory L, Bryson
openaire   +2 more sources

Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study

Lancet Diabetes and Endocrinology,the, 2013
Emanuel Christ, Damian Wild, Martin P Béhé   +2 more
exaly  

Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis

New England Journal of Medicine
openaire   +2 more sources